Abstract:Proprotein convertase subtilisin kexin type 9 (PCSK9) plays an important role in cholesterol homeostasis by enhancing the degradation of LDL receptor (LDLR) protein. Peroxisome proliferator-activated receptor γ (PPARγ) has been shown to be atheroprotective. PPARγ can be activated by ligands and/or dephosphorylation with ERK1/2 inhibitors. The effect of PPARγ on PCSK9 and LDLR expression remains unknown. In this study, we investigated the effects of PPARγ on PCSK9 and LDLR expression. At the cellular levels, PPARγ ligands induced PCSK9 mRNA and protein expression in HepG2 cells. PCSK9 expression was induced by inhibition of ERK1/2 activity but inhibited by ERK1/2 activation. The mutagenic study and promoter activity assay suggested that the induction of PCSK9 expression by ERK1/2 inhibitors was tightly linked to PPARγ dephosphorylation. However, PPARγ activation by ligands or ERK1/2 inhibitors induced hepatic LDLR expression. The promoter assay indicated that the induction of LDLR expression by PPARγ was sterol regulatory element-dependent because PPARγ enhanced sterol regulatory element-binding protein 2 (SREBP2) processing. In vivo, administration of pioglitazone or U0126 alone increased PCSK9 expression in mouse liver but had little effect on PCSK9 secretion. However, the co-treatment of pioglitazone and U0126 enhanced both PCSK9 expression and secretion. Similar to in vitro, the increased PCSK9 expression by pioglitazone and/or U0126 did not result in decreased LDLR expression and function. In contrast, pioglitazone and/or U0126 increased LDLR protein expression and membrane translocation, SREBP2 processing, and CYP7A1 expression in the liver, which led to decreased total and LDL cholesterol levels in serum. Our results indicate that although PPARγ activation increased PCSK9 expression, PPARγ activation induced LDLR and CYP7A1 expression that enhanced LDL cholesterol metabolism.

PPAR-&lt;bold&gt;&lt;roman&gt;&gamma;&lt;/roman&gt;&lt;/bold&gt; Activation Increases Insulin Secretion Independent of CASK in INS-1 Cells

Role of Peroxisome Proliferator-Activated Receptor Gamma in Glucose-Induced Insulin Secretion

Peroxisome proliferator-activated receptor-α regulates the expression of pancreatic/duodenal homeobox-1 in rat insulinoma (INS-1) cells and ameliorates glucose-induced insulin secretion impaired by palmitate

Peroxisome Proliferator-Activated Receptor-Gamma Transcriptionally Up-Regulates Hormone-Sensitive Lipase Via the Involvement of Specificity Protein-1

Down-regulation of CASK in Glucotoxicity-Induced Insulin Dysfunction in Pancreatic Β Cells.

Activation of PPARδ Up-Regulates the Expression of Insulin Gene Transcription Factor MafA and Ameliorates Glucose-Induced Insulin Secretion Impaired by Palmitate.

Calcium/calmodulin-dependent Serine Protein Kinase is Involved in Exendin-4-induced Insulin Secretion in INS-1 Cells.

Pgc-1 Alpha Coactivates Estrogen-Related Receptor-Alpha To Induce The Expression Of Glucokinase

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

CASK, APBA1, and STXBP1 collaborate during insulin secretion

AMPK Enhances the Expression of Pancreatic Duodenal Homeobox-1 Via PPARα, but Not PPARγ, in Rat Insulinoma Cell Line INS-1

Peroxisome Proliferator-activated Receptor γ Activation by Ligands and Dephosphorylation Induces Proprotein Convertase Subtilisin Kexin Type 9 and Low Density Lipoprotein Receptor Expression

Activation of PPARβ/δ Protects Pancreatic Β Cells from Palmitate-Induced Apoptosis by Upregulating the Expression of GLP-1 Receptor.

Involvement of Per-Arnt-Sim Kinase and Extracellular-Regulated Kinases-1/2 in Palmitate Inhibition of Insulin Gene Expression in Pancreatic β-Cells

Peroxisome Proliferator-Activated Receptor-Gamma Increases Adiponectin Secretion Via Transcriptional Repression Of Endoplasmic Reticulum Chaperone Protein Erp44

Structural and Biochemical Basis for the Binding Selectivity of Peroxisome Proliferator-activated Receptor Γ to PGC-1α

Forkhead Box O1 Mediates Defects in Palmitate-Induced Insulin Granule Exocytosis by Downregulation of Calcium/Calmodulin-Dependent Serine Protein Kinase Expression in Ins-1 Cells

PPARγ Activation Attenuates Glycated-Serum Induced Pancreatic Beta-Cell Dysfunction Through Enhancing Pdx1 and Mafa Protein Stability.

Specific Deletion of CASK in Pancreatic Β Cells Affects Glucose Homeostasis and Improves Insulin Sensitivity in Obese Mice by Reducing Hyperinsulinemia Running Title: Β Cell CASK Deletion Reduces Hyperinsulinemia.

Peroxisome Proliferator-Activated Receptor-Gamma Reduces ER Stress and Inflammation Via Targeting NGBR Expression

Cask methylation involved in the injury of insulin secretion function caused by interleukin1‐β

PPAR-&amp;lt;bold&amp;gt;&amp;lt;roman&amp;gt;&amp;gamma;&amp;lt;/roman&amp;gt;&amp;lt;/bold&amp;gt; Activation Increases Insulin Secretion Independent of CASK in INS-1 Cells